All Stories

  1. Amyloid-beta induces distinct forms of cell death in different neuronal populations
  2. TauP301L disengages from the proteosome core complex and neurogranin coincident with enhanced neuronal network excitability
  3. Epigallocatechin Gallate Modulates Microglia Phenotype to Suppress Pro-inflammatory Signalling Cues and Inhibit Phagocytosis
  4. Epigallocatechin Gallate Modulates Microglia Phenotype to Suppress Pro-Inflammatory Signalling Cues and Inhibit Phagocytosis
  5. Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants
  6. Chromatin interaction maps identify Wnt responsive cis-regulatory elements coordinating Paupar-Pax6 expression in neuronal cells
  7. Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein Variants
  8. A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding
  9. Neuro-nutraceuticals: Natural products nourish the brain but be aware of contrary effects
  10. Oral (−)-Epicatechin Inhibits Progressive Tau Pathology in rTg4510 Mice Independent of Direct Actions at GSK3β
  11. Chromatin interaction maps identify Wnt responsivecis-regulatory elements coordinatingPaupar-Pax6expression in neuronal cells
  12. Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action
  13. The Library Derived 4554W Peptide Inhibits Primary Nucleation of α-Synuclein
  14. The Bidirectional Relationship Between Sleep and Inflammation Links Traumatic Brain Injury and Alzheimer’s Disease
  15. A series of helical α-synuclein fibril polymorphs are populated in the presence of lipid vesicles
  16. Analysis of Protein Glycation Using Phenylboronate Acrylamide Gel Electrophoresis
  17. Excitation-Energy-Dependent Molecular Beacon Detects Early Stage Neurotoxic Aβ Aggregates in the Presence of Cortical Neurons
  18. Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer’s Disease
  19. Increased Foxo3a Nuclear Translocation and Activity is an Early Neuronal Response to βγ-Secretase-Mediated Processing of the Amyloid-β Protein Precursor: Utility of an AβPP-GAL4 Reporter Assay
  20. Structural evidence of quercetin multi-target bioactivity: A reverse virtual screening strategy
  21. Nutrition for the ageing brain: Towards evidence for an optimal diet
  22. Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer’s Disease
  23. Neuro-nutraceuticals: Further insights into their promise for brain health
  24. Neuro-nutraceuticals: The path to brain health via nourishment is not so distant
  25. Dietary (−)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing
  26. Decreased rabphilin 3A immunoreactivity in Alzheimer’s disease is associated with Aβ burden
  27. AMPA Receptor Activation Promotes Non-Amyloidogenic Amyloid Precursor Protein Processing and Suppresses Neuronal Amyloid-β Production
  28. Analysis of protein glycation using fluorescent phenylboronate gel electrophoresis
  29. Potential Neuroprotective Actions of Dietary Flavonoids
  30. Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia
  31. Prion protein expression alters APP cleavage without interaction with BACE-1
  32. Neuroprotective effects of phenolic antioxidant tBHQ associate with inhibition of FoxO3a nuclear translocation and activity
  33. Pro-oxidant diet enhances β/γ secretase-mediated APP processing in APP/PS1 transgenic mice
  34. Neuroinflammation: Modulation by flavonoids and mechanisms of action
  35. Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease
  36. Synthesis, physical–chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer’s disease
  37. Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
  38. Tumour necrosis factor alpha induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration
  39. Synaptic NMDA Receptor Activation Stimulates α-Secretase Amyloid Precursor Protein Processing and Inhibits Amyloid-β Production
  40. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury
  41. Glial metabolism of quercetin reduces its neurotoxic potential
  42. Dietary flavonoid (−)epicatechin stimulates phosphatidylinositol 3‐kinase‐dependent anti‐oxidant response element activity and up‐regulates glutathione in cortical astrocytes
  43. Aβ1–42 modulation of Akt phosphorylation via α7 nAChR and NMDA receptors
  44. Neuroprotective effects of hesperetin in mouse primary neurones are independent of CREB activation
  45. Phosphatidylinositol 3-Kinase Is a Key Mediator of Central Sensitization in Painful Inflammatory Conditions
  46. Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY‐5Y cells
  47. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons
  48. CB2 cannabinoid receptors promote mouse neural stem cell proliferation
  49. Metals ions and neurodegeneration
  50. (‐)Epicatechin stimulates ERK‐dependent cyclic AMP response element activity and up‐regulates GluR2 in cortical neurons
  51. Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro
  52. Cyclin-dependent kinase 5, Munc18a and Munc18-interacting protein 1/X11α protein up-regulation in Alzheimer’s disease
  53. Activity‐dependent phosphorylation of Akt/PKB in adult DRG neurons
  54. Zinc–histidine complex protects cultured cortical neurons against oxidative stress-induced damage
  55. Flavonoids: antioxidants or signalling molecules?
  56. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones
  57. Expression of SOD1 G93A or wild‐type SOD1 in primary cultures of astrocytes down‐regulates the glutamate transporter GLT‐1: lack of involvement of oxidative stress
  58. Modulation of Pro-survival Akt/Protein Kinase B and ERK1/2 Signaling Cascades by Quercetin and Its in Vivo Metabolites Underlie Their Action on Neuronal Viability
  59. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites
  60. The ‘glial’ glutamate transporter, EAAT2 (Glt‐1) accounts for high affinity glutamate uptake into adult rodent nerve endings
  61. Noxious Stimulation Induces Trk Receptor and Downstream ERK Phosphorylation in Spinal Dorsal Horn
  62. Cyclothiazide Unmasks an AMPA-Evoked Release of Arachidonic Acid from Cultured Striatal Neurones
  63. Glucose Regulates Glutamate-Evoked Arachidonic Acid Release from Cultured Striatal Neurons
  64. Hydrogen Peroxide Enhances Signal-Responsive Arachidonic Acid Release from Neurons: Role of Mitogen-Activated Protein Kinase
  65. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide
  66. Phosphatidylinositol 3‐kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones
  67. Hydrogen peroxide‐mediated phosphorylation of ERK1/2, 
Akt/PKB and JNK in cortical neurones: dependence 
on Ca2+ and PI3‐kinase
  68. Contrasting influences of glucuronidation and O -methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts
  69. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3
  70. Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein
  71. Ca2+-Permeable AMPA Receptors Induce Phosphorylation of cAMP Response Element-Binding Protein through a Phosphatidylinositol 3-Kinase-Dependent Stimulation of the Mitogen-Activated Protein Kinase Signaling Cascade in Neurons
  72. Genes encoding multiple forms of phospholipase A2 are expressed in rat brain
  73. Reduction of gaba and glutamate transporter messenger rnas in the severe-seizure genetically epilepsy-prone rat
  74. Ethanol modulates N-methyl-d-aspartate-evoked arachidonic acid release from neurones
  75. Reduced glucose metabolism enhances the glutamate-evoked release of arachidonic acid from striatal neurons
  76. Effects of acute and chronic ethanol on cyclic AMP accumulation in NG108-15 cells: differential dependence of changes on extracellular adenosine
  77. Inhibition of ADP-ribosyltransferase increases synthesis of Gsα in neuroblastoma × glioma hybrid cells and reverses iloprost-dependent heterologous loss of fluoride-sensitive adenylate cyclase
  78. Specific binding sites for human luteinizing hormone in Neurospora crassa and Saccharomyces cerevisiae
  79. Gsα-dependent and -independent desensitisation of prostanoid IP receptor-activated adenylyl cyclase in NG108-15 cells
  80. Chronic Ethanol Reduces Immunologically Detectable Gqα/11α in NG108–15 Cells
  81. Binding sites for LH in Candida albicans: comparison with the mammalian corpus luteum LH receptor
  82. Characterization of a factor(s) from partially purified human gonadotrophin preparations which inhibit(s) the binding of radiolabelled human LH and human chorionic gonadotrophin to Candida albicans
  83. Receptor-mediated elevation of adenylate cyclase by luteinizing hormone in Candida albicans
  84. Specific, high-affinity binding sites for human luteinizing hormone (hLH) and human chorionic gonadotrophin (hCG) in candida species
  85. Measurement of Adenylyl Cyclase Activity in Cell Membranes